Prevalence and factors associated with polypharmacy in older people with cancer.
about
A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).Geriatric Assessment of Older Adults With Cancer During Unplanned Hospitalizations: An Opportunity in Disguise.Patients Aged 80 Years or Older are Encountered More Potentially Inappropriate Medication UseAnalgesic Use and Pain in Robust, Pre-Frail and Frail Older Outpatients with Cancer.Old age, high risk medication, polypharmacy: a 'trilogy' of risks in older patients with atrial fibrillation.Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging StudyClinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives.Attributes of primary care in relation to polypharmacy: a multicenter cross-sectional study in Japan.Polypharmacy and potentially inappropriate medication use in geriatric oncology.Cardio-oncology in the older adult.What is polypharmacy? A systematic review of definitions.Statin use and pain in older people with cancer: a cross-sectional study.Factors associated with use of falls risk-increasing drugs among patients of a geriatric oncology outpatient clinic in Australia: a cross-sectional study.FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.Polypharmacy in the Geriatric Oncology Population.Polypharmacy and patterns of prescription medication use among cancer survivors.
P2860
Q30276856-6CF393D5-5838-4A1B-A5A7-22C33DC6F681Q34276134-00948AC8-B4F7-43A2-8C55-6928CCDA6CDEQ35820580-3A68A1F7-874D-4817-99FC-E7D82E53EED7Q36701688-C933D460-ACD2-4DED-A738-18F75B9426ADQ36942819-2284C8FE-BE1C-4DAE-874F-844EC4A72949Q37060185-B3E514BD-1B0C-49F7-91A1-39C01F284C16Q37138558-3283B2AE-A1F5-4154-846B-390C63CEB0A3Q38844615-06E66025-A789-4A93-9C99-0DA21AB437BBQ38858489-94D9B071-C4CF-4A71-89E3-5800A0F825BFQ38920892-CA99C2B2-B821-4500-87A2-AE0A8C7CA363Q39303131-7B0CD49D-93EC-4D12-96C6-A24DC2EE1BE1Q42374534-469AA952-6737-45C2-9590-66B38D53996DQ46975648-95B03C35-7475-4F93-AA0F-186F425D7A52Q48099014-B4E98B57-A92A-421E-8602-15C918C2DAA2Q48297666-9801A31B-7A99-40A7-B898-6333FCE1DEADQ49887562-36E0376B-A4B9-4D4F-BDA0-C4A2E26F1971Q53412548-F1BE3868-BB65-472E-A54C-0585DC1C3AC2
P2860
Prevalence and factors associated with polypharmacy in older people with cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Prevalence and factors associated with polypharmacy in older people with cancer.
@en
Prevalence and factors associated with polypharmacy in older people with cancer.
@nl
type
label
Prevalence and factors associated with polypharmacy in older people with cancer.
@en
Prevalence and factors associated with polypharmacy in older people with cancer.
@nl
prefLabel
Prevalence and factors associated with polypharmacy in older people with cancer.
@en
Prevalence and factors associated with polypharmacy in older people with cancer.
@nl
P2093
P2860
P1476
Prevalence and factors associated with polypharmacy in older people with cancer.
@en
P2093
J Simon Bell
Jonathon Hogan-Doran
Nimit Singhal
Robert Prowse
Sally Johns
Sepehr Shakib
P2860
P2888
P304
P356
10.1007/S00520-014-2171-X
P577
2014-03-02T00:00:00Z
P5875
P6179
1043053990